Literature DB >> 11574744

Antiviral action of Euphorbium compositum and its components.

B Glatthaar-Saalmüller1, P Fallier-Becker.   

Abstract

INTRODUCTION: Euphorbium compositum SN (Biologische Heilmittel Heel GmbH, Baden-Baden, Germany, a homeopathic combination preparation available in form of drops, nasal spray, and injection solution), is prescribed for inflammation of the mucosae of the nose and sinuses. Infections in these areas are primarily of viral origin although bacterial superinfections are also common.
OBJECTIVE: The main question was whether or not this homeopathic remedy shows an activity against viruses responsible for infections of the respiratory tract.
METHODS: This in vitro study using virus plaque reduction assays examined the effect of Euphorbium compositum SN against pathogens causing various viral infections: influenza A virus, respiratory syncytial virus (RSV), human rhinovirus (HRV) and herpes simplex virus type 1 (HSV-1).
RESULTS: Analysis of virus production after treatment of the infected cells with the remedy showed an antiviral activity of Euphorbium compositum SN against RSV and HSV-1. In addition, an antiviral effect against influenza A virus and HRV, though minimal, was, also noted. Analyses of the plant-derived components of Euphorbium compositum SN, e.g. Euphorbium resinifera, Pulsatilla pratensis and Luffa operculata for their antiviral activity revealed a clear activity of Euphorbium resinifera and Pulsatilla pratensis against RSV. In contrast, no effect was detected using the same protocol with Luffa operculata.
CONCLUSIONS: Euphorbium resinifera and Pulsatilla pratensis as components of Euphorbium compositum SN are responsible for its antiviral activity. Copyright 2001 S. Karger GmbH, Freiburg

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574744     DOI: 10.1159/000057223

Source DB:  PubMed          Journal:  Forsch Komplementarmed Klass Naturheilkd        ISSN: 1424-7364


  4 in total

Review 1.  Homotoxicology--a review of randomised clinical trials.

Authors:  E Ernst; K Schmidt
Journal:  Eur J Clin Pharmacol       Date:  2004-06-09       Impact factor: 2.953

Review 2.  Pharmacological activities and molecular mechanisms of Pulsatilla saponins.

Authors:  Jinmiao Zhong; Lihua Tan; Meiwan Chen; Chengwei He
Journal:  Chin Med       Date:  2022-05-23       Impact factor: 4.546

3.  Immunology and homeopathy. 4. Clinical studies-part 1.

Authors:  Paolo Bellavite; Riccardo Ortolani; Francesco Pontarollo; Valeria Piasere; Giovanni Benato; Anita Conforti
Journal:  Evid Based Complement Alternat Med       Date:  2006-07-05       Impact factor: 2.629

4.  In vitro antimicrobial activity of Luffa operculata.

Authors:  Rodolfo Alexander Scalia; José Eduardo Lutaif Dolci; Suely Mitoi Ykko Ueda; Suzethe Matiko Sassagawa
Journal:  Braz J Otorhinolaryngol       Date:  2014-12-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.